Emraclidine

• 11/15/2024

  AbbVie’s Schizophrenia Treatment Fails: What’s Next?

• 11/13/2024

  AbbVie’s Schizophrenia Drug Fails, Bristol Myers Squibb Gains Edge

• 

  10/3/2024

  **Emraclidine: A Potential Game-Changer for Schizophrenia Treatment**